改良自然周期体外受精中活产率保持稳定 despite 低抗苗勒管激素:638个周期分析
本研究为回顾性队列研究,纳入638例年龄≤39岁、在大学附属私立体外受精中心启动首个改良自然周期体外受精(mnIVF)周期的女性,按血清抗苗勒管激素(AMH)浓度分为三组。结果显示,各AMH百分位组的每启动周期活产率相当(第25百分位、25-75百分位、第75百分位分别为11.6%、12.4%、17.0%),AMH百分位并非活产的显著预测因素。作者结论认为血清AMH不能用于预测mnIVF结局。
要点
- 各AMH百分位组每启动周期活产率相当:11.6%、12.4%、17.0%
- AMH百分位不是活产的显著预测因素
- 低/高AMH百分位患者的妊娠率和活产率与AMH正常者相当
核心结论
- 血清AMH不能用于预测mnIVF结局。
- 低/高AMH百分位患者的妊娠率和活产率与AMH正常者相当。
研究设计与样本
- 回顾性队列研究,纳入638例年龄≤39岁、在大学附属私立体外受精中心启动首个mnIVF周期的女性。
- 按AMH浓度分为三组:≤0.5 ng/ml(第25百分位)、0.51-2.03 ng/ml(25-75百分位,参照组)、2.04-6.56 ng/ml(第75百分位)。
- 分析按AMH百分位和患者年龄(<35岁、35-39岁)分层,采用逻辑回归评估年龄和AMH百分位对结局的影响。
- 主要结局指标为活产率。
主要发现
- 每启动周期活产率在各AMH百分位组间相当:第25百分位为11.6%,25-75百分位为12.4%,第75百分位为17.0%。
- 三组在取消周期、成功取卵、胚胎移植、生化妊娠率和临床妊娠率方面均无统计学显著差异。
- 逻辑回归分析未将AMH百分位识别为活产的显著预测因素。
- 与参照组相比,<第25百分位组和>第75百分位组的活产比值比(OR [95%置信区间,CI])分别为0.97(0.54-1.76)和1.41(0.82-2.41)。
- 无论年龄组(<35岁、35-39岁)如何,结果均相同。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RESEARCH QUESTION: Do live birth rates (LBR) following modified natural IVF (mnIVF) differ according to serum anti-Müllerian hormone (AMH) concentration? DESIGN: Retrospective cohort study including 638 women aged ≤39 years starting their first mnIVF cycle at a university-affiliated private IVF centre. Patients were divided into three groups, by concentration of AMH: ≤0.5 ng/ml (25th percentile), 0.51-2.03 ng/ml (25-75th percentile, reference) and 2.04-6.56 ng/ml (75th percentile). Analyses were stratified by AMH percentile and the age of patients (<35, 35-39 years). Logistic regression assessed the impact of age and AMH percentile on outcomes. LBR was the primary outcome measure. RESULTS: LBR per started cycle were comparable across AMH percentiles (11.6%, 12.4% and 17.0% for the 25th, 25-75th and 75th percentile, respectively). No statistically significant difference was found between the three AMH groups with respect to cancellation, successful egg retrieval, embryo transfer, or biochemical and clinical pregnancy rates. Logistic regression analysis did not identify AMH percentile as a significant predictor of live birth. Compared with the reference group, the odds ratios (OR [95% confidence interval, CI]) for live birth in the <25th and >75th AMH percentile groups were 0.97 (0.54-1.76) and 1.41 (0.82-2.41), respectively. The results were the same regardless of age group (<35 years, 35-39 years). CONCLUSIONS: Serum AMH cannot be used to predict mnIVF outcomes. Patients in lower/upper AMH percentiles showed pregnancy and LBR comparable to patients with normal AMH.
引用
- Preaubert L, Shaulov T, Phillips S, et al. Live birth rates remain stable in modified natural IVF despite low anti-Müllerian hormone: analysis of 638 cycles. Reprod Biomed Online. 2019. PMID: 31272809. doi:10.1016/j.rbmo.2019.04.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。